Common Wegovy side effects include nausea, vomiting, diarrhoea, and constipation, particularly during dose escalation due to slowed gastric emptying
No, GLP-1 therapy is not for everyone
Pain or discomfort at the injection site is a recognised adverse effect, reported in clinical trials and post-marketing surveillance
Provider-led assessment and dose adjustment may reduce side effects and optimize response, though outcomes depend on individual physiology, medication quality, and adherence
This could involve adjusting the semaglutide dose, implementing additional medications to manage cardiovascular health, or providing specific lifestyle recommendations to reduce the risk of chest pain
Frequently asked questions (FAQs) What are semaglutide withdrawal symptoms